The outcome of using intravenous immunoglobulin (IVIG) in critically ill COVID-19 patients’: a retrospective, multi-centric cohort study

BACKGROUND: During the COVID-19 pandemic, different treatments have been used in critically ill patients. Using intravenous immunoglobulin (IVIG) has been suggested in various studies as an effective option. Our study aims to access the efficacy of IVIG in critically ill COVID-19 patients. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Salehi, Mohammadreza, Barkhori Mehni, Mahdi, Akbarian, Mohammadmehdi, Fattah Ghazi, Samrand, Khajavi Rad, Nasim, Moradi Moghaddam, Omid, Jamali Moghaddam, SaeedReza, Hosseinzadeh Emam, Masoumeh, Abtahi, Sayed Hamidreza, Moradi, Maryam, Ghiasvand, Fereshteh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8811009/
https://www.ncbi.nlm.nih.gov/pubmed/35115056
http://dx.doi.org/10.1186/s40001-022-00637-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8811009/
https://www.ncbi.nlm.nih.gov/pubmed/35115056
http://dx.doi.org/10.1186/s40001-022-00637-8

Ejemplares similares